HighTower Advisors’s ACELYRIN SLRN Stock Holding History

HighTower Advisors’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,031	Closed	-$24.8K	–	3954
2025 Q1	$24.8K	Sell	10,031 -155	-2%	-$369	﹤0.01%	3506
2024 Q4	$32K	Sell	10,186 -42	-0.4%	-$203	﹤0.01%	3499
2024 Q3	$50K	Buy	+10,228	New	+$52.8K	﹤0.01%	3415

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HighTower Advisors's SLRN Position: Q2 2025 in Review

HighTower Advisors sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 10,031 shares — an estimated $24.8K sold.

HighTower Advisors first reported a position in SLRN in Q3 2024 and held it in 3 quarters. The position peaked at $50K in Q3 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

HighTower Advisors reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
HighTower Advisors sold 10,031 ACELYRIN shares in Q2 2025, an estimated $24.8K.
HighTower Advisors first reported a position in ACELYRIN in Q3 2024 and held it in 3 quarters.
HighTower Advisors's ACELYRIN position peaked at $50K in Q3 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on HighTower Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.